Jen Monnier is an intern at Spectrum. She is a journalist in New York City, covering medicine, technology and ecosystems. She’s also a graduate student at New York University’s Science, Health and Environmental Reporting program.
Jen Monnier
From this contributor
Early interventions, explained
The accepted wisdom in autism research holds that early intervention offers the best promise for an autistic child’s well-being. But how effective are these therapies?
Multipart device monitors various senses in babies
A new assemblage of tools precisely gauges a baby’s biological response to sights, sounds and tactile stimuli all at once.
Multipart device monitors various senses in babies
By
Jen Monnier
17 August 2018 | 2 min read
New consortium may create projects, funding for autism research
A newly formed group of leaders from the U.S. National Institutes of Health (NIH) is poised to generate funding opportunities for child health research, including autism science.
New consortium may create projects, funding for autism research
By
Jen Monnier
2 August 2018 | 3 min read
Glowing capsule illuminates problems in gut
An ingestible electronic capsule enables researchers to instantaneously detect molecules associated with gastrointestinal issues.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read